33 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 33 of 33 clinical reviews.
NMN and NR (nicotinamide riboside) may interact with warfarin through NAD+ metabolism, CYP enzyme competition, and platelet effects. A pharmacist-level guide to risks, monitoring, and dose adjustment.
A board-reviewed clinical guide covering NMN/NR (nicotinamide mononucleotide/riboside) interactions with anesthesia and perioperative care, including when to stop, why it matters, and what the evidence shows.
Can you take NMN or NR with acetaminophen? A guide to the hepatic metabolism overlap, NAD+ depletion concerns, CYP enzyme pathways, and what to verify before combining them long-term.
A guide to the pharmacokinetic and pharmacodynamic considerations of combining nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) with apixaban (Eliquis).
A clinician-level review of the pharmacokinetic and pharmacodynamic interaction between NMN/NR (nicotinamide mononucleotide/riboside) and atorvastatin, covering CYP3A4 mechanisms, safety evidence, monitoring, and dosing guidance.
Evidence-based analysis of NMN/NR (nicotinamide mononucleotide/riboside) interactions with benzodiazepines, covering CYP metabolism, CNS effects, monitoring protocols, and dose-adjustment strategies.
A guide to the NMN/NR and bupropion drug interaction, covering CYP2D6 pharmacokinetics, seizure-threshold risk, monitoring parameters, and safe co-administration strategies.
A guide to the NMN/NR and cannabis interaction profile, covering metabolism, NAD+ pathway effects, cardiovascular overlap, and practical safety guidance for patients combining these agents.
Can you safely take NMN or NR (nicotinamide mononucleotide/riboside) with clopidogrel? We break down the CYP2C19 pharmacokinetic overlap, clinical risk, monitoring, and dose-adjustment guidance.
Can you take NMN or NR with diphenhydramine? Review the pharmacokinetic and pharmacodynamic interaction profile, safety data, monitoring guidance, and dose-adjustment considerations for combining NAD+ precursors with this common antihistamine.
A clinician-level review of the pharmacokinetic and pharmacodynamic interactions between NMN/NR (nicotinamide mononucleotide/riboside) and estradiol HRT, including mechanism, monitoring, and dosing guidance.
Can you take NMN or NR (nicotinamide mononucleotide/riboside) with finasteride? A clinician-level review of pharmacokinetic overlap, androgen-pathway considerations, and monitoring recommendations.
Can you take NMN or NR (nicotinamide mononucleotide/riboside) with gabapentin? A guide covering pharmacokinetic overlap, renal considerations, monitoring protocols, and dose-adjustment strategies.
A guide to the interaction between nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) and hormonal contraceptives, covering CYP enzyme pathways, NAD+ biology, estrogen metabolism, and practical dosing guidance.
Can you take NMN or NR supplements with levothyroxine? Review of absorption risks, CYP metabolism, timing protocols, and TSH monitoring guidance for combining NAD+ precursors with thyroid hormone replacement.
Can you take NMN or NR with metformin? A clinical review of the pharmacokinetic and pharmacodynamic interaction between nicotinamide mononucleotide/riboside and metformin, including monitoring, dosing, and safety data.
A breakdown of the NMN/NR and nicotine interaction, covering shared NAD+ pathways, SIRT1 competition, cardiovascular additive risks, and practical dosing guidance.
A guide to the pharmacological interaction between NMN/NR (nicotinamide mononucleotide/riboside) and NSAIDs such as ibuprofen and naproxen, covering mechanism, risk, monitoring, and dosing.
Can you take NMN or NR supplements with opioid pain medications? A clinical review of nicotinamide mononucleotide/riboside interactions with oxycodone, hydrocodone, and tramadol, including CYP metabolism, severity ratings, and monitoring.
A guide to taking NMN or NR with proton pump inhibitors. Covers absorption mechanisms, CYP2C19 considerations, gastric pH effects on NAD precursors, monitoring, and practical dosing guidance.
Can you take NMN or NR (nicotinamide mononucleotide/riboside) with prednisone? A clinical review of pharmacodynamic overlap, glucose effects, bone density risks, immune modulation, and monitoring recommendations.
Can you take NMN or NR (nicotinamide mononucleotide/riboside) with pregabalin? A analysis of pharmacokinetic and pharmacodynamic interactions, monitoring recommendations, and dose-adjustment considerations.
Can you take NMN or NR with progesterone hormone replacement therapy? Review of pharmacokinetic and pharmacodynamic interactions, sedation overlap risk, CYP enzyme considerations, and monitoring recommendations.
Can you take NMN or NR supplements with rivaroxaban (Xarelto)? Review of CYP3A4, P-glycoprotein pathways, severity rating, monitoring parameters, and dose-adjustment considerations.
A clinician-level review of the pharmacokinetic and pharmacodynamic interaction between NMN/NR (nicotinamide mononucleotide/riboside) and rosuvastatin, including mechanism, severity, monitoring, dose adjustment, and patient counseling.
Can you take NMN or NR (nicotinamide mononucleotide/riboside) with sildenafil? A guide covering pharmacokinetic overlap, blood-pressure effects, monitoring, and dose-adjustment advice.
A clinician-grade review of the pharmacokinetic and pharmacodynamic interaction between NMN/NR (nicotinamide mononucleotide/riboside) and simvastatin, covering CYP3A4 overlap, myopathy risk, monitoring thresholds, and patient counseling.
Clinical review of the interaction between NAD+ precursors (NMN, nicotinamide riboside) and SNRI antidepressants (venlafaxine, duloxetine), covering CYP metabolism, serotonin pathway overlap, blood pressure effects, and hepatic safety.
A look at combining NMN or NR (NAD precursors) with SSRIs like sertraline and escitalopram. Covers mechanism, serotonin syndrome risk, CYP enzymes, monitoring, and patient counseling.
Can you take NMN or NR (nicotinamide mononucleotide/riboside) with tadalafil? A guide to the pharmacokinetic and pharmacodynamic questions, blood pressure considerations, and what still needs to be verified with a prescriber.
A breakdown of the NMN/NR (nicotinamide mononucleotide/riboside) and trazodone interaction, covering pharmacokinetic and pharmacodynamic mechanisms, sedation overlap, CYP enzyme effects, and practical dosing guidance.
Can NMN or NR be taken with zolpidem? See what is known, what has not been studied, label-confirmed zolpidem interactions, and a practical medication-review plan.
A comprehensive clinical review of how NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) interact with vaccines, including immune effects, timing guidance, and alcohol use during supplementation.